Article Type
Case Series
Published
Three clinical cases are presented in this article to illustrate the position of pemigatinib in the management of cholangiocarcinoma and related toxicities.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.